PREDICTORS FOR OFF-THERAPY HBEAG SERO-REVERSION HEPATITIS AND HBEAG-NEGATIVE HEPATITIS IN HBEAG-POSITIVE PATIENTS DISCONTINUE NUC THERAPY ARE DIFFERENT

被引:0
|
作者
Peng, Chien-Wei [1 ,2 ]
Jeng, Wen-Juei [1 ,2 ]
Chien, Rong-Nan [1 ,2 ,3 ]
Liaw, Yun-Fan [2 ,4 ]
机构
[1] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Gastroenterol & Hepatol, Taoyuan, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Linkou Branch, Liver Res Unit, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp, Liver Res Unit, Linkou, Taiwan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
797
引用
收藏
页码:489A / 490A
页数:2
相关论文
共 50 条
  • [21] Different clinical features of spontaneous decrease of HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B patients
    Liu, J.
    Peng, L.
    Yan, Y.
    Cao, H.
    Zhang, S. -Q.
    Deng, Z. -D.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S72 - S72
  • [22] HbeAg-negative chronic hepatitis B results in more severe liver disease than HBeAg-positive chronic hepatitis B
    Mahtab, M.
    Rahman, S.
    Khan, M.
    LIVER INTERNATIONAL, 2006, 26 : 55 - 55
  • [23] Prediction of liver histopathology by non-invasive models in HBeAG-positive and HBeAG-negative chronic hepatitis B
    Roberts, S.
    Lau, G. K.
    Piratvisuth, T.
    Luo, K.
    Marcellin, P.
    Bonino, F.
    Farci, P.
    McCloud, P.
    Button, P.
    Popescu, M.
    Cooksley, G.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S196 - S196
  • [24] Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B
    Croagh, Catherine M. N.
    Bell, Sally J.
    Slavin, John
    Kong, Yu X. G.
    Chen, Robert Y.
    Locarnini, Stephen
    Desmond, Paul V.
    LIVER INTERNATIONAL, 2010, 30 (08) : 1115 - 1122
  • [25] Characteristic of 158 cases' liver pathology in HbeAg-positive and HbeAg-negative patients with CHB
    Ma, Jun-Ji
    Feng, Li-Ying
    Feng, Zhi-Jie
    Jiang, Hui-Qing
    Sun, Ze-Ming
    Zhao, Li-Mei
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 915 - 915
  • [26] PREDICTION OF HBsAg KINETICS AND HBEAG LOSS DURING ANTIVIRAL THERAPY IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B
    Kim, Hwi Young
    Jang, Tae Soo
    Lee, Joo Ho
    Lee, Hye Ah
    Kwon, Hee-Dae
    HEPATOLOGY, 2020, 72 : 518A - 518A
  • [27] EARLY HBEAG LOSS DURING LAMIVUDINE THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS WITH ACUTE EXACERBATION
    Peng, Cheng-Yuan
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    HEPATOLOGY, 2009, 50 (04) : 515A - 515A
  • [28] Predictors of response in patients with HBeAG-positive chronic hepatitis B using adefovir dipivoxil therapy
    Li, J.
    Zhao, H.
    Si, C-W.
    Zhang, Y-X.
    Chen, X-Y.
    Wang, L.
    Tang, X-P.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S199 - S200
  • [29] HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
    Fried, Michael W.
    Piratvisuth, Teerha
    Lau, George K. K.
    Marcellin, Patrick
    Chow, Wan-Cheng
    Cooksley, Graham
    Luo, Kang-Xian
    Paik, Seung Woon
    Liaw, Yun-Fan
    Button, Peter
    Popescu, Matei
    HEPATOLOGY, 2008, 47 (02) : 428 - 434
  • [30] Correlation between serum HBcrAg levels and intrahepatic replication activity in HBeAg-positive and HBeAg-negative chronic hepatitis B
    Chuaypen, Natthaya
    Payungporn, Sunchai
    Tanaka, Yasuhito
    Tangkijvanich, Pisit
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 372 - 372